Sepsis is a clinical diagnosis, and clinicians should be permitted to make the diagnosis appropriately.
When I step up onto my sepsis soapbox, people often refer to New York State and tell me how they are not allowed to accept Sepsis-3, pursuant to state regulation. Full disclosure: I hail from New York.
I’ve read the regulations. Here’s what they say regarding adult sepsis (from Volume C (Title 10); Chapter V; Subchapter A; Article 2; Section 405.4 (Sepsis Regulations: Guidance Document 405.4 (a)(4)):
All of these sound reasonable. We all agree that reducing overall mortality is a worthy goal.
The devil is in the details when you read the New York Department of Health analysis of the outcomes of the Office of the Medical Director and the Office of Quality and Patient Safety (NYS Report on Sepsis Care Improvement Initiative: Hospital Quality Performance).
It says that “sepsis is a life-threatening condition that requires early detection and timely, appropriate interventions to improve the chances of survival and optimize outcomes for patients of all ages.” It defines sepsis as “a clinical syndrome in which patients have an infection that is accompanied by an extreme systemic response.” Contemplate this: is having a fever and a corresponding tachycardia an “extreme” systemic response?
It is true that “for the purposes of data collection,” they use Sepsis-2 definitions: sepsis is defined as confirmed or suspected infection accompanied by two systemic inflammatory response syndrome (SIRS) criteria; severe sepsis is defined as sepsis (as defined above), complicated by organ dysfunction; adult septic shock is defined as sepsis-induced hypotension persisting despite adequate IV fluid resuscitation and/or evidence of tissue hypoperfusion. However, their protocols only mandate treatment of severe sepsis and septic shock, just like SEP-1.
This report specifies on page 5 that they are using “the term ‘sepsis’ to indicate severe sepsis and septic shock.” Can we make this more confusing?! If you have three categories (i.e., sepsis, severe sepsis, and septic shock), it is completely unacceptable to use the term “sepsis” to only indicate severe sepsis and septic shock!
Their performance measures mirror SEP-1. In fact, they acknowledge that “the alignment with CMS SEP-1 measure was intended to reduce measure abstraction burden for hospitals, and to minimize the confusion resulting from the discrepancy between NYS and CMS sepsis measures.”
The report’s authors are scrutinizing the medical care of severe sepsis and septic shock patients. As in the Centers for Medicare & Medicaid Services’ (CMS’s) SEP-1, patients without organ dysfunction, even if they trigger general variable systemic inflammatory response syndrome (SIRS) (e.g., fever or hypothermia, tachycardia, tachypnea, abnormal WBC), as per their definition of sepsis, are not included in the measures. The statistics noted in their Sepsis Measure Summary Report only refer to the treatment of severe sepsis and septic shock.
In conclusion, “early detection” of sepsis, when defined as confirmed or presumed infection with two SIRS criteria, leads to nowhere in New York State, CMS, or anywhere else. There is no mandated treatment until the organ dysfunction threshold is crossed (i.e., severe sepsis). Organ dysfunction is where Sepsis-3 starts.
While folks maintain that treatment of “early sepsis” will save lives, there is no evidence that anyone is looking at outcomes of treatment of sepsis prior to the development of organ dysfunction. New York State is not. There is no “early sepsis” category in any sepsis schema.
Finally, the Sepsis Initiative Improvement report noted that on Nov. 14, 2018, the regulation was amended to “clarify that sepsis definitions…are for the purposes of hospital data collection and reporting and are not intended to direct clinical care (my italics for emphasis).” Sepsis is a clinical diagnosis, and clinicians should be permitted to make the diagnosis appropriately. There are no gold standard diagnostic criteria, not SIRS, not sequential organ failure assessment (SOFA).
I reiterate: sepsis is life-threatening organ dysfunction due to dysregulated systemic host response to infection (i.e., the condition formerly known as “severe sepsis). It should be treated aggressively to try to prevent mortality. If you are concerned a patient is developing sepsis, treat it aggressively. If no organ dysfunction ensues, the patient never developed sepsis. Maybe you averted it.
SIRS may be a harbinger of sepsis, but it is not a defining characteristic, nor a diagnostic criterion. Acknowledge it, address it, but do not rely on it to make the diagnosis of sepsis, severe sepsis, or septic shock, whether you live in New York or not.
Programming Note:
Listen to Dr. Erica Remer’s reports live on Talk Ten Tuesday every Tuesday, 10-10:30 a.m. EST.
That’s how Centers for Medicare & Medicaid Services (CMS) Administrator Mehmet Oz announced the publication of the CMS Final Rule on the Adoption of Standards
It just seems that a week does not go by when an insurance company doesn’t develop a new policy that leads to confusion in the
Please log in to your account to comment on this article.
Breast biopsy procedures may be clinically straightforward but accurately translating them into compliant billing can be anything but. In this focused webcast, Shawn Blackburn, CPC, CPMA, CIC, CRC, CCS-P breaks down how imaging guidance, lesion count, laterality, and payer expectations all impact how these procedures should be reported. Through clear explanations and real-world scenarios, you’ll gain practical insight into aligning clinical workflows with billing requirements, avoiding common pitfalls, and ensuring your documentation supports accurate reimbursement and compliance.
Gain clarity and confidence in OB‑GYN coding with this expert‑led webcast featuring Sherri L. Clayton, RHIT, CSS. You’ll learn how to apply global maternity package rules accurately, select the right CPT codes for procedures and visits, and identify documentation gaps that lead to denials. With practical guidance and real examples, this session helps you strengthen compliance, reduce audit risk, and ensure accurate reimbursement for women’s health services.
Uncover essential coding insights with nationally recognized coding authority Kay Piper, RHIA, CDIP, CCS. Through ICD10monitor’s interactive, on‑demand webcast series, Kay walks you through the AHA’s 2026 ICD‑10‑CM/PCS Quarterly Coding Clinics, translating each update into practical, easy‑to‑apply guidance designed to sharpen precision, ensure compliance, and strengthen day‑to‑day decision‑making. Available shortly after each official release.
Uncover critical guidance on the ICD-10-CM/PCS code updates. Kay Piper reviews and explains ICD-10-CM/PCS coding guidelines in the AHA’s fourth quarter 2026 ICD-10-CM/PCS Coding Clinic in an easy to access on-demand webcast.
Traditional utilization management models can no longer keep pace with regulatory shifts, payer scrutiny, and operational pressures. In this webcast, Tiffany Ferguson, LMSW, CMAC, ACM, ACPA-C, introduces an Adaptive Model strategy that modernizes UM through role specialization, technology-driven workflows, and proactive, team-based processes. Attendees will learn how to restructure programs to improve efficiency, strengthen clinical collaboration, and enhance financial performance in a rapidly changing healthcare environment.
Federal auditors are intensifying their focus on inpatient psychiatric facilities, using advanced data analytics to spotlight outliers and pursue high‑dollar repayments. In this high‑impact webcast, Michael Calahan, PA, MBA, Compliance Officer and V.P., Hospital & Physician Compliance, breaks down what regulators are really targeting in IPF-PPS admissions, documentation, treatment and discharge planning. Attendees will learn practical steps to tighten processes, avoid common audit triggers and protect reimbursement and reduce the risk of multimillion-dollar repayment demands.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Happy HIP Week! Sign up to win free access to our 2026 Coding Clinic Update Webcast Series! Click here to learn more →
Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more
Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
